Legal & General Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $670K | Buy |
|
|||||
|
2025
Q2 | $84.7K | Buy |
|
|||||
|
2025
Q1 | $35.5K | Buy |
|
|||||
|
2024
Q4 | $34.4K | Sell |
|
|||||
|
2024
Q3 | $24.7K | Buy |
|
|||||
|
2024
Q2 | $18.1K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $5K | Sell |
|
|||||
|
2022
Q1 | $84K | Buy |
|
|||||
|
2021
Q4 | $253K | Buy |
|
|||||
|
2021
Q3 | $308K | Buy |
|
|||||
|
2021
Q2 | $293K | Buy |
|
|||||
|
2021
Q1 | $116K | Buy |
|
|||||
|
2020
Q4 | $96K | Sell |
|
|||||
|
2020
Q3 | $87K | Sell |
|
|||||
|
2020
Q2 | $523K | Buy |
|
|||||
|
2020
Q1 | $161K | Sell |
|
|||||
|
2019
Q4 | $165K | Hold |
|
|||||
|
2019
Q3 | $102K | Buy |
|
|||||
|
2019
Q2 | $110K | Buy |
|
|||||
|
2019
Q1 | $137K | Hold |
|
|||||
|
2018
Q4 | $93K | Buy |
|
|||||
|
2018
Q3 | $66K | Hold |
|
|||||
|
2018
Q2 | $75K | Sell |
|
|||||
|
2018
Q1 | $79K | Sell |
|
|||||
|
2017
Q4 | $167K | Sell |
|
|||||
|
2017
Q3 | $225K | Buy |
|
|||||
|
2017
Q2 | $142K | Buy |
|
|||||
|
2017
Q1 | $83K | Sell |
|
|||||
|
2016
Q4 | $97K | Buy |
|
|||||
|
2016
Q3 | $38K | Hold |
|
|||||
|
2016
Q2 | $32K | Hold |
|
|||||
|
2016
Q1 | $39K | Buy |
|
|||||
|
2015
Q4 | $12K | Buy |
|